Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 1
1959 2
1960 1
1994 1
1997 1
1999 1
2001 1
2003 4
2004 4
2006 2
2007 2
2008 2
2010 2
2011 2
2012 1
2013 1
2014 5
2015 5
2016 3
2017 3
2018 3
2019 1
2020 4
2021 9
2022 13
2023 6
2024 5
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

74 results

Results by year

Filters applied: . Clear all
Page 1
[18F]fluorodeoxyglucose and [18F]fluorocholine PET-CT for staging optimisation and treatment modification in hepatocellular carcinoma (PET-HCC01): a prospective multicentre study.
Nault JC, Boubaya M, Wartski M, Dohan A, Pol S, Pop G, Soussan M, Sutter O, Costentin C, Roux J, Sengel C, Lequoy M, Montravers F, Menu Y, Pageaux GP, Goulart DM, Guiu B, Luciani A, Nahon P, Dioguardi Burgio M, Wagner M, Maksud P, Mulé S, Allaire M, Sidali S, Coilly A, Besson FL, Lewin M, Regnault H, Hollande C, Amaddeo G, Ronot M, Ganne-Carrié N, Itti E, Bloch-Queyrat C, Levy V, Lebtahi R, Chalaye J, Bouattour M. Nault JC, et al. Among authors: sengel c. Lancet Gastroenterol Hepatol. 2025 Apr;10(4):306-314. doi: 10.1016/S2468-1253(25)00011-1. Epub 2025 Feb 20. Lancet Gastroenterol Hepatol. 2025. PMID: 39987937 Clinical Trial.
Prognostic role of radiomics-based body composition analysis for the 1-year survival for hepatocellular carcinoma patients.
Saalfeld S, Kreher R, Hille G, Niemann U, Hinnerichs M, Öcal O, Schütte K, Zech CJ, Loewe C, van Delden O, Vandecaveye V, Verslype C, Gebauer B, Sengel C, Bargellini I, Iezzi R, Berg T, Klümpen HJ, Benckert J, Gasbarrini A, Amthauer H, Sangro B, Malfertheiner P, Preim B, Ricke J, Seidensticker M, Pech M, Surov A. Saalfeld S, et al. Among authors: sengel c. J Cachexia Sarcopenia Muscle. 2023 Oct;14(5):2301-2309. doi: 10.1002/jcsm.13315. Epub 2023 Aug 17. J Cachexia Sarcopenia Muscle. 2023. PMID: 37592827 Free PMC article.
Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial.
Vilgrain V, Pereira H, Assenat E, Guiu B, Ilonca AD, Pageaux GP, Sibert A, Bouattour M, Lebtahi R, Allaham W, Barraud H, Laurent V, Mathias E, Bronowicki JP, Tasu JP, Perdrisot R, Silvain C, Gerolami R, Mundler O, Seitz JF, Vidal V, Aubé C, Oberti F, Couturier O, Brenot-Rossi I, Raoul JL, Sarran A, Costentin C, Itti E, Luciani A, Adam R, Lewin M, Samuel D, Ronot M, Dinut A, Castera L, Chatellier G; SARAH Trial Group. Vilgrain V, et al. Lancet Oncol. 2017 Dec;18(12):1624-1636. doi: 10.1016/S1470-2045(17)30683-6. Epub 2017 Oct 26. Lancet Oncol. 2017. PMID: 29107679 Clinical Trial.
Tubulocystic renal cell carcinoma: a new radiological entity.
Cornelis F, Hélénon O, Correas JM, Lemaitre L, André M, Meuwly JY, Sengel C, Derchi L, Yacoub M, Verkarre V, Grenier N. Cornelis F, et al. Among authors: sengel c. Eur Radiol. 2016 Apr;26(4):1108-15. doi: 10.1007/s00330-015-3923-9. Epub 2015 Jul 24. Eur Radiol. 2016. PMID: 26201293 Review.
Polytraumatism and solid organ bleeding syndrome: The role of imaging.
Thony F, Rodière M, Frandon J, Vendrell A, Jankowski A, Ghelfi J, Sengel C, Arvieux C, Bouzat P, Ferretti G. Thony F, et al. Among authors: sengel c. Diagn Interv Imaging. 2015 Jul-Aug;96(7-8):707-15. doi: 10.1016/j.diii.2015.06.004. Epub 2015 Jul 20. Diagn Interv Imaging. 2015. PMID: 26206744 Free article. Review.
Skeletal muscle quality predicts overall survival in advanced liver hepatocellular carcinoma treated with SIRT and sorafenib: A subanalysis of the SORAMIC trial.
Surov A, Wienke A, Borggrefe J, Hinnerichs M, Seidensticker R, Öcal O, Schütte K, Zech CJ, Loewe C, van Delden O, Vandecaveye V, Verslype C, Gebauer B, Sengel C, Bargellini I, Iezzi R, Malfertheiner P, Berg T, Klümpen HJ, Benckert J, Gasbarrini A, Amthauer H, Sangro B, Ricke J, Seidensticker M. Surov A, et al. Among authors: sengel c. United European Gastroenterol J. 2024 Oct;12(8):1016-1027. doi: 10.1002/ueg2.12627. Epub 2024 Jul 15. United European Gastroenterol J. 2024. PMID: 39007783 Free PMC article. Clinical Trial.
Gadoxetic acid-based hepatobiliary MRI in hepatocellular carcinoma.
Ricke J, Steffen IG, Bargellini I, Berg T, Bilbao Jaureguizar JI, Gebauer B, Iezzi R, Loewe C, Karçaaltincaba M, Pech M, Sengel C, van Delden O, Vandecaveye V, Zech CJ, Seidensticker M. Ricke J, et al. Among authors: sengel c. JHEP Rep. 2020 Aug 24;2(6):100173. doi: 10.1016/j.jhepr.2020.100173. eCollection 2020 Dec. JHEP Rep. 2020. PMID: 33103093 Free PMC article.
Transarterial Radioembolisation with Y90 Resin Microspheres and the Effect of Reimbursement Criteria in France: Final Results of the CIRT-FR Prospective Observational Study.
Ronot M, Loffroy R, Arnold D, Greget M, Sengel C, Pinaquy JB, Pellerin O, Maleux G, Peynircioglu B, Pelage JP, Schaefer N, Sangro B, de Jong N, Zeka B, Urdaniz M, Helmberger T, Vilgrain V. Ronot M, et al. Among authors: sengel c. Cardiovasc Intervent Radiol. 2025 Feb;48(2):205-220. doi: 10.1007/s00270-024-03955-y. Epub 2025 Jan 14. Cardiovasc Intervent Radiol. 2025. PMID: 39809885 Free PMC article.
Prognostic value of baseline imaging and clinical features in patients with advanced hepatocellular carcinoma.
Öcal O, Ingrisch M, Ümütlü MR, Peynircioglu B, Loewe C, van Delden O, Vandecaveye V, Gebauer B, Zech CJ, Sengel C, Bargellini I, Iezzi R, Benito A, Pech M, Malfertheiner P, Ricke J, Seidensticker M. Öcal O, et al. Among authors: sengel c. Br J Cancer. 2022 Feb;126(2):211-218. doi: 10.1038/s41416-021-01577-6. Epub 2021 Oct 22. Br J Cancer. 2022. PMID: 34686780 Free PMC article. Clinical Trial.
74 results